FDA Inspection
Central Pennsylvania Blood BankCentral Pennsylvania Blood Bank – FDA Inspection, Apr 24, 2026
Record Details
This FDA Inspection record concerns Central Pennsylvania Blood Bank, with an inspection on April 24, 2026, issued by the Philadelphia District Office, covering biologics.
View Company Profile
ID · 4c07ce87-56cf-40e1-9f6b-fc6e59b15abd
Inspection Facts
- Inspection number
- 1313800
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 630.10(e)(1)Medical Assessment Factors
- 21 CFR 630.15(b)(3)Weight
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Central Pennsylvania Blood Bank
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 6, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Central Pennsylvania Blood Bank
- FDA Inspection 1171011 - 2022-05-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.